Research in Patrik Brundin’s laboratory focuses on pathogenetic mechanisms and pharmacological treatment in cell and animal models of Parkinson’s disease. The group’s mission is to understand neurodegenerative diseases and develop new therapies that are of benefit to patients and their caregivers.
That's a wrap on another great Great Challenges in Parkinson's Disease and Rallying to the Challenge! Thank you to all those who attended, our outstanding speakers and our generous sponsors! ... See MoreSee Less
Our next featured speaker is Dr. Subhojit Roy, principal investigator at the University of Wisconsin, Madison. Dr. Roy works to understand trafficking pathways involved in physiology and disease, including the role of alpha-synuclein in Parkinson’s disease ... See MoreSee Less
Due to their complex geometry and finite sites of bulk protein synthesis (perikarya), neurons have evolved elaborate transport and trafficking machineries to deliver proteins into axons and dendrites. The Roy lab is interested in understanding trafficking pathways involved in physiology and disease,...